# Huzhou Zhanwang Pharmaceutical Co., Ltd. – FDA Inspection, Mar 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/huzhou-zhanwang-pharmaceutical-co-ltd/5587637b-649c-4642-b8b3-ef1a785ddaf9
Source feed: FDA_Inspections

> FDA inspection 1237589 of Huzhou Zhanwang Pharmaceutical Co., Ltd., March 29, 2024. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237589
- Company Name: Huzhou Zhanwang Pharmaceutical Co., Ltd.
- Inspection Date: 2024-03-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 966455 - 2016-04-08
- FDA Inspection 850476 - 2013-09-13
- FDA Inspection 683244 - 2010-09-16

## Related Officers

- [Investigator](https://www.keypedia.com/people/damaris-y-hernandez/ca16093e-047b-4bf1-bcc1-c439cff21e8a)
- [FDA Associated Person](https://www.keypedia.com/people/suzanne-n-vallez/7c16e0f4-c0b1-4f50-adfa-b1dc534694cd)

Company: https://www.keypedia.com/companies/huzhou-zhanwang-pharmaceutical-co-ltd/d4cf8da8-dece-46c3-bbc9-c12134a94b73

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c